| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kairos Pharma, Ltd. (KAPA) has 7 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. KAPA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.31M | $566.7K | - | |
| VP | 299.5K | $129.4K | - | |
| CFO | 293.0K | $126.6K | - | |
| CEO | 230.1K | $99.4K | - | |
| Dir | 73.4K | $31.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | Murali Ramachandran | VP Of Research And Development | Buy | 200 | $1.59 | $318.00 | +0.2% | -30.0% | -56.8% | |
| Nov 22, 2024 | Samuelson Doug | Chief Financial Officer | Buy | 2,500 | $1.50 | $3,750.00 | +4.3% | -16.9% | -58.0% | |
| Nov 20, 2024 | Yu John S | CEO And Chairman | Buy | 4,000 | $1.44 | $5,760.00 | - | -8.9% | -53.0% |